The exoribonuclease XRN2 mediates degradation of the long non‐coding telomeric RNA TERRA

Abstract
The telomeric repeat-containing RNA, TERRA, associates with both telomeric DNA and telomeric proteins, often forming RNA:DNA hybrids (R-loops). TERRA is most abundant in cancer cells utilizing the alternative lengthening of telomeres (ALT) pathway for telomere maintenance, suggesting that persistent TERRA R-loops may contribute to activation of the ALT mechanism. Therefore, we sought to identify the enzyme(s) that regulate TERRA metabolism in mammalian cells. Here, we identify that the 5 '-3 ' exoribonuclease XRN2 regulates the stability of TERRA RNA. Moreover, while stabilization of TERRA alone was insufficient to drive ALT, depletion of XRN2 in ALT-positive cells led to a significant increase in TERRA R-loops and exacerbated ALT activity. Together, our findings highlight XRN2 as a key determinant of TERRA metabolism and telomere stability in cancer cells that rely on the ALT pathway.
Funding Information
  • Clinical and Translational Science Institute, Boston University (1UL1TR001430)
  • Genome Science Institute, Boston University
  • Center for Scientific Review (R01CA201446, R01CA214880, R35GM146769)
  • National Center for Advancing Translational Sciences
  • National Institutes of Health